Resource Center
Explore Resource Types
We have housed the technical documents (SDS, COAs, Manuals and more) in a dedicated section.
Explore all All resources
Filters
Select resource types
Select products & services
Select solutions (2)
Active filters (2)
Clear all
145 - 156 of 205 Results
Sort by:
Best match

miRNA Exosomes App Note
Gel-free library prep using miRNA isolated from exosomes.

Gene editing of primary immune cells to aid next-generation cellular immunotherapies
Researchers have successfully deployed CRISPRa/i in primary human T cells, offering critical insights into the pathways required for cytokine regulation.

Utilization of AlphaLISA technology to accurately detect asthma biomarkers in human serum
In this application note, AlphaLISA technology was used to quantify biomarker levels in serum samples, specifically Human IL-21, IL-33, and TNFα.

Ex Vivo Functional Drug Testing of 3D Patient-Derived Cancer Cells Shows Promise for Personalized Medicine
Demonstrating how functional testing of 3D patient-derived cancer cells enables effective drug sensitivity testing.

Solutions for precision medicine research
Our wide range of technologies can help you gain the knowledge you need to identify genomic vulnerabilities, screen functional responses, and evaluate how well a treatment is working.

Biologics workflow solutions
Revvity can help you discover and develop high-quality biological drug products by streamlining the biologics workflow.

Improving precision stratification using patient-derived model systems
Precision stratification using patient-derived model systems.

An emerging therapeutic modality - RNA carves its path out of the paradigm
Learn more about several promising classes of RNA therapeutic, including RNAi, CRISPR, base editing, and mRNA vaccines, as well as the potential to combine RNA technologies with CAR-T.

Streamlining the development of bispecific antibodies from expression to quality assessment with Revvity’s biotherapeutic workflow solutions
Expression and characterization of bispecific antibodies with a combination of CHOSOURCE TnT Transposon Technology and LabChip to streamline biotherapeutic workflows

Performing AlphaLISA assays with RPMI-1640
This application note provides alternatives for working with samples in RPMI medium, which contains high levels of biotin

Alpha technologies for antibody detection and characterization
Alpha technology is homogeneous and non-radiometric with distinct features that makes it enabling in comparison to other proximity assays.

cAMP assay provides flexibility and stable pharmacology
AlphaScreen™ technology provides a quantitative detection of molecules in a homogeneous, no-wash format and can be applied to GPCR research.


Looking for technical documents?
Find the technical documents you need, ASAP, in our easy-to-search library.